News

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025 ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June ...
Gosforth man who was first recruit on aspirin trial to prevent bowel cancer celebrates results
Nick James, from Gosforth, signed up to the CaPP3 trial - which has found that a daily dose of 75-100mg aspirin cuts risk of ...
C&EN1d
Discovery of a “True” Aspirin Prodrug | Journal of Medicinal Chemistry - ACS Publications
Aspirin prodrugs formed by derivatization at the benzoic acid group are very difficult to obtain because the promoiety accelerates the rate of hydrolysis by plasma esterases at the neighboring acetyl ...
ahajournals.org2d
Drug Interactions Affecting Oral Anticoagulant Use | Circulation: Arrhythmia and Electrophysiology - AHA/ASA Journals
Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to ...